Company / Accounts Receivable
Heartflow, Inc. Accounts Receivable History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$29.3M
FY2025
5-year range
$29.3M / $29.3M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#125 of 138
Health Care
What the data says
Among 138 Health Care companies, Heartflow, Inc. is in the bottom 9% for accounts receivable.
Based on SEC 10-K filings.
$29M in FY2025.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 138This company $29.3M Sector average $1.3B
▼
-97.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026